Advanced drug delivery approaches against periodontitis

Drug Delivery

Volumn 23, Issue 2, 2016, Pages 363-377

  Joshi, Deeksha ^a   Garg, Tarun ^a   Goyal, Amit K ^a   Rath, Goutam ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Controlled drug delivery; microflora; nanocarriers; patient compliance; periodontitis

Indexed keywords

ANTIBIOTIC AGENT; LIPOSOME; NANOFIBER; NANOPARTICLE; ANTIINFECTIVE AGENT; DRUG CARRIER; POLYMER;

ARTICLE; DRUG DELIVERY DEVICE; FIBER; FILM; GEL; HUMAN; IMMUNE RESPONSE; LOW DRUG DOSE; MUCOADHESION; PATIENT COMPLIANCE; PERIODONTITIS; PRIORITY JOURNAL; STRIP; ADHESION; ANIMAL; BACTERIUM; CHEMISTRY; DRUG EFFECTS; DRUG FORMULATION; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; NANOTECHNOLOGY; ORAL DRUG ADMINISTRATION; PERIODONTAL POCKET; PHARMACEUTICS; PROCEDURES;

ADHESIVENESS; ADMINISTRATION, ORAL; ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIA; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; PERIODONTAL POCKET; PERIODONTITIS; POLYMERS; TECHNOLOGY, PHARMACEUTICAL;

EID: 84954314378     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2014.935531     Document Type: Article

References (156)

1. Abu Fanas S, Drucker D, Hull, P. (1991). Evaluation of acrylic strips containing amoxycillin with clavulanic acid for local drug delivery. J Dent 19: 92-6
2. Addy M, Hassan H, Moran J, et al. (1988). Use of antimicrobial containing acrylic strips in the treatment of chronic periodontal disease: a three month follow-up study. J Periodontol 59: 557-64
3. Agarwal E, Pradeep A, Bajaj P, Naik SB. (2012). Efficacy of local drug delivery of 0.5% clarithromycin gel as an adjunct to non-surgical periodontal therapy in the treatment of current smokers with chronic periodontitis: a randomized controlled clinical trial. J Periodontol 83: 1155-63
4. Ahuja A, Ali J, Rahman S. (2006a). Biodegradable periodontal intrapocket device containing metronidazole and amoxycillin: formulation and characterisation. Die Pharmazie Int J Pharm Sci 61: 25-9
5. Ahuja A, Ali J, Sarkar R, et al. (2003). Targeted retentive device for oro-dental infections: formulation and development. Int J Pharm 259: 47-55
6. Ahuja A, Ali J, Shareef A, Khar R. (2006b). Formulation and development of targeted retentive device for the treatment of periodontal infections with amoxycillin trihydrate. Indian J Pharm Sci 68: 442-47
7. Ahuja A, Baiju C, Ahuja V. (2012). Role of antibiotics in generalized aggressive periodontitis: a review of clinical trials in humans. J Indian Soc Periodontol 16: 317-23
8. Aishwarya S, Mahalakshmi S, Sehgal PK. (2008). Collagen-coated polycaprolactone microparticles as a controlled drug delivery system. J Microencap 25: 298-306
9. Akincibay H, Şenel S, Yetkin Ay, Z. (2007). Application of chitosan gel in the treatment of chronic periodontitis. J Biomed Mater Res B Appl Biomater 80: 290-6
10. Albandar JM, Streckfus CF, Adesanya MR, Winn DM. (2000). Cigar, pipe, and cigarette smoking as risk factors for periodontal disease and tooth loss. J Periodontol 71: 1874-81
11. Anderson H. (1996). Treatment of chronic periodontitis: a site-specific fiber placement technique. Pract Periodontics Aesthet Dent 8: 565-70; Quiz 572
12. Arora N, Singh K, Garg T. (2012). Areas of nanomedicine applications. Int J Univ Pharm Life Sci 2: 216-27
13. Arweiler NB, Pietruska M, Pietruski J, et al. (2014). Six-month results following treatment of aggressive periodontitis with antimicrobial photodynamic therapy or amoxicillin and metronidazole. Clin Oral Invest 1-7. [Epub ahead of print]
14. Bakó J, Szepesi M, Márton I, et al. (2007). Synthesis of nanoparticles for dental drug delivery systems. Fogorvosi Szemle 100: 109-13
15. Bakó J, Vecsernyés M, Ujhelyi Z, et al. (2013). Composition and characterization of in situ usable light cured dental drug delivery hydrogel system. J Mater Sci Mater Med 24: 659-66
16. Bansal K, Rawat M, Jain A, et al. (2009). Development of satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS Pharmscitech 10: 716-23
17. Bergström J. (1989). Cigarette smoking as risk factor in chronic periodontal disease. Comm Dent Oral Epidemiol 17: 245-7
18. Bottino MC, Arthur RA, Waeiss RA, et al. (2014). Biodegradable nanofibrous drug delivery systems: effects of metronidazole and ciprofloxacin on periodontopathogens and commensal oral bacteria. Clin Oral Investig. [Epub ahead of print]
19. Brogden KA, Guthmiller JM. (2002). Polymicrobial diseases. Washington, DC: ASM Press
20. Bruschi ML, De Freitas O, Lara EH, et al. (2008). Precursor system of liquid crystalline phase containing propolis microparticles for the treatment of periodontal disease: development and characterization. Drug Develop Ind Phar 34: 267-78
21. Bruschi ML, Jones DS, Panzeri H, et al. (2007). Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties. J Pharm Sci 96: 2074-89
22. Çetin EÖ, Buduneli N, Atlihan E, Kirilmaz L. (2005). In vitro studies of a degradable device for controlled-release of meloxicam. J Clin Periodontol 32: 773-7
23. Chang HI, Lau YC, Yan C, Coombes A. (2008). Controlled release of an antibiotic, gentamicin sulphate, from gravity spun polycaprolactone fibers. J Biomed Mater Res A 84: 230-7
24. Chaturvedi T, Srivastava R, Srivastava A, et al. (2013). Doxycycline poly e-caprolactone nanofibers in patients with chronic periodontitis-a clinical evaluation. J Clin Diagn Res 7: 2339-42
25. Chaturvedi TP, Srivastava R, Srivastava AK, et al. (2012). Evaluation of metronidazole nanofibers in patients with chronic periodontitis: a clinical study. Int J Pharm Invest 2: 213-17
26. Corry D, Moran J. (1998). Assessment of acrylic bone cement as a local delivery vehicle for the application of non-steroidal anti-inflammatory drugs. Biomaterials 19: 1295-301
27. Dabhi MR, Nagori SA, Gohel MC, et al. (2010). Formulation development of smart gel periodontal drug delivery system for local delivery of chemotherapeutic agents with application of experimental design. Drug Deliv 17: 520-31
28. Dabhi MR, Sheth NR. (2013). Formulation development of physiological environment responsive periodontal drug delivery system for local delviery of metronidazole benzoate. Drug Dev Ind Phar 39: 425-36
29. De Sousa FO, Blanco-Méndez J, Pérez-Estévez A, et al. (2012). Effect of zein on biodegradable inserts for the delivery of tetracycline within periodontal pockets. J Biomater Appl 27: 187-200
30. Deasy P, Collins AE, Maccarthy DJ, Russell R. (1989). Use of strips containing tetracycline hydrochloride or metronidazole for the treatment of advanced periodontal disease. J Pharm Pharmacol 41: 694-9
31. Dhadse P, Gattani D, Mishra R. (2010). The link between periodontal disease and cardiovascular disease: how far we have come in last two decades? J Indian Soc Periodontol 14: 148-54
32. Di L, Pi-Shan Y, Deyu H, Fuxiang L. (2013). Minocycline hydrochloride liposome controlled-release gel improves rat experimental periodontitis. West China J Stomatol 31: 592-6
33. Di Turi G, Riggio C, Vittorio O, et al. (2011). Sub-micrometric liposomes as drug delivery systems in the treatment of periodontitis. Int J Immunopathol Pharmacol 25: 657-70
34. El-Kamel AH, Ashri LY, Alsarra IA. (2007). Micromatricial metronidazole benzoate film as a local mucoadhesive delivery system for treatment of periodontal diseases. AAPS Pharmscitech 8: E184-94
35. Emingil G, Gürkan A, Atilla G, et al. (2006). Adjunctive low-dose doxycycline therapy effect on clinical parameters and gingival crevicular fluid tissue plasminogen activator levels in chronic periodontitis. Inflam Res 55: 550-8
36. Esfahanian V, Shamami MS, Shamami MS. (2012). Relationship between osteoporosis and periodontal disease: review of the literature. J Dent (Tehran, Iran) 9: 256-64
37. Esposito E, Cortesi R, Cervellati F, et al. (1997). Biodegradable microparticles for sustained delivery of tetracycline to the periodontal pocket: formulatory and drug release studies. J Microencap 14: 175-87
38. Fan M, Wei G, Liu N, Ling J. (1992). A study on resorbable local metronidazol delivery devices. Shanghai Kou Qiang Yi Xue Shanghai J Stomatol 1: 22-4
39. Flemmig TF, Petersilka G, Völp A, et al. (2011). Efficacy and safety of adjunctive local moxifloxacin delivery in the treatment of periodontitis. J Periodontol 82: 96-105
40. Friesen LR, Williams KB, Krause LS, Killoy WJ. (2002). Controlled local delivery of tetracycline with polymer strips in the treatment of periodontitis. J Periodontol 73: 13-19
41. Gagandeep G, Garg T, Malik B, et al. (2014). Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur J Pharm Sci 53: 10-16
42. Garg T. (2014). Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol 1-8
43. Garg T, Bilandi A, Kapoor B. (2011a). Current status and future directions of new drug delivery technologies. Int Res J Pharm 2: 61-8
44. Garg T, Bilandi A, Kapoor B. (2011b). Scaffold: tissue engineering and regenerative medicine. Int Res J Pharm 2: 37-42
45. Garg T, Goyal AK. (2012). Iontophoresis: drug delivery system by applying an electrical potential across the skin. Drug Deliv Lett 2: 270-80
46. Garg T, Goyal AK. (2014a). Biomaterial-based scaffolds-current status and future directions. Expert Opin Drug Deliv 11: 767-89
47. Garg T, Goyal AK. (2014b). Liposomes: targeted and controlled delivery system. Drug Deliv Lett 4: 62-71
48. Garg T, Goyal AK. (2014c). Medicated chewing gum: patient compliance oral drug delivery system. Drug Deliv Lett 4: 72-8
49. Garg T, Goyal AK, Arora S, Murthy R. (2012a). Development, optimization & evaluation of porous chitosan scaffold formulation of gliclazide for the treatment of type-2 diabetes mellitus. Drug Deliv Lett 2: 251-61
50. Garg T, Rath G, Goyal AK. (2014). Comprehensive review on additives of topical dosage forms for drug delivery. Drug Deliv. [Epub ahead of print]
51. Garg T, Singh O, Arora S. (2011c). Opportunities and growth of conduct clinical trials in India. Int J Pharm Sci Rev Res 8: 152-60
52. Garg T, Singh O, Arora S, Murthy R. (2011d). Dendrimer-a novel scaffold for drug delivery. Int J Pharma Sci Rev Res 7: 211-20
53. Garg T, Singh O, Arora S, Murthy R. (2011e). Patented microencapsulation techniques and its application. J Pharm Res 4: 2097-102
54. Garg T, Singh O, Arora S, Murthy R. (2012b). Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst 29: 1-63
55. Garg T, Singh S, Goyal AK. (2013). Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst 30: 369-409
56. Golomb G, Friedman M, Soskolne A, et al. (1984). Sustained release device containing metronidazole for periodontal use. J Dental Res 63: 1149-53
57. Goodson J, Cugini M, Kent R, et al. (1991). Multicenter evaluation of tetracycline fiber therapy: II. Clinical response. J Periodontal Res 26: 371-9
58. Goodson J, Haffajee A, Socransky S. (1979). Periodontal therapy by local delivery of tetracycline. J Clin Periodontol 6: 83-92
59. Goodson J, Hogan P, Dunham S. (1985). Clinical responses following periodontal treatment by local drug delivery. J Periodontol 56: 81-7
60. Goodson J, Holborow D, Dunn R, et al. (1983). Monolithic tetracycline-containing fibers for controlled delivery to periodontal pockets. J Periodontol 54: 575-9
61. Govender S, Lutchman D, Pillay V, et al. (2006). Enhancing drug incorporation into tetracycline-loaded chitosan microspheres for periodontal therapy. J Microencap 23: 750-61
62. Goyal AK, Rath G, Garg T. (2013a). Nanotechnological approaches for genetic immunization. In: DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases. RNA Technologies. pp 67-120
63. Goyal G, Garg T, Malik B, et al. (2013b). Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv. [Epub ahead of print]
64. Griffiths G, Smart G, Bulman J, et al. (2000). Comparison of clinical outcomes following treatment of chronic adult periodontitis with subgingival scaling or subgingival scaling plus metronidazole gel. J Clin Periodontol 27: 910-17
65. Guiglia R, Di-Fede O, Lo-Russo L, et al. (2013). Osteoporosis, jawbones and periodontal disease. Medicina Oral, Patologia Oral Y Cirugia Bucal 18: E93-99
66. Gupta R, Pandit N, Aggarwal S, Verma A. (2008). Comparative evaluation of subgingivally delivered 10% doxycycline hyclate and xanthan-based chlorhexidine gels in the treatment of chronic periodontitis. J Contemp Dent Pract 9: 25-32
67. Heijl L, Dahlen G, Sundin Y, et al. (1991). A 4-quadrant comparative study of periodontal treatment using tetracycline-containing drug delivery fibers and scaling. J Clin Periodontol 18: 111-16
68. Herrera D, Matesanz P, Bascones-Martínez A, Sanz M. (2012). Local and systemic antimicrobial therapy in periodontics. J Evid Based Dent Pract 12: 50-60
69. Hirasawa M, Takada K, Makimura M, Otake S. (2002). Improvement of periodontal status by green tea catechin using a local delivery system: a clinical pilot study. J Periodontal Res 37: 433-8
70. Huang Z-M, Zhang Y-Z, Kotaki M, Ramakrishna S. (2003). A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Comp Sci Technol 63: 2223-53
71. Ikinci G, Şenel S, Akincibay H, et al. (2002). Effect of chitosan on a periodontal pathogen Porphyromonas gingivalis. Int J Pharma 235: 121-7
72. Inanç B, Arslan YE, Seker S, et al. (2009). Periodontal ligament cellular structures engineered with electrospun poly (dl-lactide-co-glycolide) nanofibrous membrane scaffolds. J Biomed Mater Res A 90: 186-95
73. Ismail G, Dumitriu HT, Dumitriu AS, Ismail FB. (2013). Periodontal disease: a covert source of inflammation in chronic kidney disease patients. Int J Nephrol 2013: 1-6
74. Jacob S. (2012). Global prevalence of periodontitis: a literarure review. Int Arab J Dentistry 3: 26-30
75. Jain N, Jain GK, Javed S, et al. (2008). Recent approaches for the treatment of periodontitis. Drug Discov Today 13: 932-43
76. Jamal T, Rahman A, Mirza A, et al. (2012). Formulation, antimicrobial and toxicity evaluation of bioceramic based ofloxacin loaded biodegradable microspheres for periodontal infection. Current Drug Deliv 9: 515-26
77. Jayaprakash S, Halith SM, Firthouse P, et al. (2009). Preparation and evaluation of biodegradable microspheres of methotrexate. Asian J Pharm 3: 26-29
78. Ji QX, Zhao QS, Deng J, Lü R. (2010). A novel injectable chlorhexidine thermosensitive hydrogel for periodontal application: preparation, antibacterial activity and toxicity evaluation. J Mater Sci Mater Med 21: 2435-42
79. Jin H, Wu W, Shu R. (2010). Doxycycline nano-liposome slow-release gel improves rat periodontitis. Shanghai Kou Qiang Yi Xue Shanghai J Stomatol 19: 508-11
80. Johannsen A, Tellefsen M, Wikesjö U, Johannsen G. (2009). Local delivery of hyaluronan as an adjunct to scaling and root planing in the treatment of chronic periodontitis. J Periodontol 80: 1493-7
81. Johnston D, Choonara YE, Kumar P, et al. (2013). Prolonged delivery of ciprofloxacin and diclofenac sodium from a polymeric fibre device for the treatment of peridontal disease. Biomed Res Int 2013: 460936
82. Kataria K, Sharma A, Garg T, et al. (2014). Novel technology to improve drug loading in polymeric nanofibers. Drug Deliv Lett 4: 79-86
83. Kaur M, Garg T, Rath G, Goyal AK. (2014a). Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst 31: 49-88
84. Kaur M, Malik B, Garg T, et al. (2014b). Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv. [Epub ahead of print]
85. Kaur R, Garg T, Malik B, et al. (2014c). Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs. Drug Deliv 1-6. [Epub ahead of print]
86. Kearns VR, Williams RL, Mirvakily F, et al. (2013). Guided gingival fibroblast attachment to titanium surfaces: an in vitro study. J Clin Periodontol 40: 99-108
87. Kimura S, Toda H, Shimabukuro Y, et al. (1991). Topical chemotherapy in human periodontitis using a new controlled-release insert containing ofloxacin. I. Microbiological observation. J Periodont Res 26: 33-41
88. Klepac-Ceraj V, Patel N, Song X, et al. (2011). Photodynamic effects of methylene blue-loaded polymeric nanoparticles on dental plaque bacteria. Lasers Surg Med 43: 600-6
89. Kong LX, Peng Z, Li SD, Bartold PM. (2006). Nanotechnology and its role in the management of periodontal diseases. Periodontology 2000 40: 184-96
90. Kumari N, Pathak K. (2012). Dual controlled release, in situ gelling periodontal sol of metronidazole benzoate and serratiopeptidase: statistical optimization and mechanistic evaluation. Curr Drug Deliv 9: 74-84
91. Kyun K, Yun K, Young J, et al. (1990). Development of minocycline containing polycaprolactone film as a local drug delivery. Taehan Ch'ikkwa Uisa Hyophoe Chi 28: 279-90
92. Labib GS, Aldawsari HM, Badr-Eldin SM. (2014). Metronidazole and pentoxifylline films for the local treatment of chronic periodontal pockets: preparation, in vitro evaluation and clinical assessment. Expert Opin Drug Deliv 11: 855-65
93. Lalla E, Papapanou PN. (2011). Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat Rev Endocrinol 7: 738-48
94. Leung WK, Jin L, Yau JY, et al. (2005). Microflora cultivable from minocycline strips placed in persisting periodontal pockets. Arch Oral Biol 50: 39-48
95. Liu D, Yang P. (2012). Minocycline hydrochloride nanoliposomes inhibit the production of TNF- in LPS-stimulated macrophages. Int J Nanomed 7: 4769-75
96. Lu Z, Rong K, Li J, et al. (2013). Size-dependent antibacterial activities of silver nanoparticles against oral anaerobic pathogenic bacteria. J Mater Sci Mater Med 24: 1465-71
97. Maheshwari M, Miglani G, Mali A, et al. (2006). Development of tetracycline-serratiopeptidase-containing periodontal gel: formulation and preliminary clinical study. AAPS Pharmscitech 7: E162-71
98. Maze GI, Reinhardt RA, Agarwal RK, et al. (1995). Response to intracrevicular controlled delivery of 25% tetracycline from poly (lactide/glycolide) film strips in SPT patients. J Clin Periodontol 22: 860-7
99. Maze GI, Reinhardt RA, Payne JB, et al. (1996). Gingival fluid tetracycline release from bioerodible gels. J Clin Periodontol 23: 1133-6
100. Mcgaw T. (2002). Periodontal disease and preterm delivery of low-birth-weight infants. J Can Dent Assoc 68: 165-9
101. Minabe M, Takeuchi K, Nishimura T, et al. (1991). Therapeutic effects of combined treatment using tetracycline-immobilized collagen film and root planing in periodontal furcation pockets. J Clin Periodontol 18: 287-90
102. Minabe M, Uematsu A, Nishijima K, et al. (1989). Application of a local drug delivery system to periodontal therapy: I. Development of collagen preparations with immobilized tetracycline. J Periodontol 60: 113-17
103. Moran J, Addy M, Wade W, Newcombe R. (1990). The use of antimicrobial acrylic strips in the non-surgical management of chronic periodontitis. Clin Mater 6: 123-35
104. Moulari B, Lboutounne H, Chaumont J-P, et al. (2006). Potentiation of the bactericidal activity of Harungana madagascariensis Lam. ex Poir. (Hypericaceae) leaf extract against oral bacteria using poly (d, l-Lactide-Co-Glycolide) nanoparticles: in vitro study. Acta Odontol 64: 153-8
105. Mundargi Rc SS, Agnihotri SA, Patil SA, et al. (2007). Development and evaluation of novel biodegradable microspheres based on poly(d, l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies. J Control Release 119: 59-68
106. Nair SC, Anoop K. (2012). Intraperiodontal pocket: an ideal route for local antimicrobial drug delivery. J Adv Pharma Technol Res 3: 9-15
107. Napimoga MH, Da Silva CA, Carregaro V, et al. (2012). Exogenous administration of 15d-Pgj2-loaded nanocapsules inhibits bone resorption in a mouse periodontitis model. J Immunol 189: 1043-52
108. Noyan Ü, Yilmaz S, Kuru B, et al. (1997). A clinical and microbiological evaluation of systemic and local metronidazole delivery in adult periodontitis patients. J Clin Periodontol 24: 158-65
109. Ozcan G, Taner I, Doganay T, et al. (1994). Use of membranes containing 20% chlorhexidine and 40% doxycycline for treatment of chronic periodontal pockets. J Nihon Univ School Dent 36: 191-8
110. Özmeriç N, Özcan G, Haytaç CM, et al. (2000). Chitosan film enriched with an antioxidant agent, taurine, in fenestration defects. J Biomed Mater Res 51: 500-3
111. Parnami N, Garg T, Rath G, Goyal AK. (2013). Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotechnol
112. Perugini P, Genta I, Conti B, et al. (2003). Periodontal delivery of ipriflavone: new chitosan/PLGA film delivery system for a lipophilic drug. Int J Pharm 252: 1-9
113. Petelin M, Pavlica Z, Ivanusa T, et al. (2000). Local delivery of liposome-encapsulated superoxide dismutase and catalase suppress periodontal inflammation in beagles. J Clin Periodontol 27: 918-25
114. Pichayakorn W, Boonme P. (2013). Evaluation of cross-linked chitosan microparticles containing metronidazole for periodontitis treatment. Mater Sci Eng C 33: 1197-202
115. Pihlstrom BL, Michalowicz BS, Johnson NW. (2005). Periodontal diseases. Lancet 366: 1809-20
116. Polson AM, Garrett S, Stoller NH, et al. (1997). Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. II. Clinical results. J Periodontol 68: 119-26
117. Pradeep A, Bajaj P, Agarwal E, et al. (2013a). Local drug delivery of 0.5% azithromycin in the treatment of chronic periodontitis among smokers. Aust Dent J 58: 34-40
118. Pradeep A, Kumari M, Rao NS, Naik SB. (2013b). 1% Alendronate gel as local drug delivery in the treatment of class II furcation defects: a randomized controlled clinical trial. J Periodontol 84: 307-15
119. Pradeep A, Priyanka N, Kalra N, et al. (2012a). Clinical efficacy of subgingivally delivered 1.2-mg simvastatin in the treatment of individuals with class II furcation defects: a randomized controlled clinical trial. J Periodontol 83: 1472-9
120. Pradeep A, Sharma A, Rao NS, et al. (2012b). Local drug delivery of alendronate gel for the treatment of patients with chronic periodontitis with diabetes mellitus: a double-masked controlled clinical trial. J Periodontol 83: 1322-8
121. Pragati S, Ashok S, Kuldeep S. (2011). Recent advances in periodontal drug delivery systems. Int J Drug Deliv 1: 1-9
122. Preshaw PM, Hefti AF, Jepsen S, et al. (2004). Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis. J Clin Periodontol 31: 697-707
123. Rao N, Pradeep A, Bajaj P, et al. (2013). Simvastatin local drug delivery in smokers with chronic periodontitis: a randomized controlled clinical trial. Aust Dent J 58: 156-62
124. Rao SK, Setty S, Acharya AB, Thakur SL. (2012). Efficacy of locally-delivered doxycycline microspheres in chronic localized periodontitis and on Porphyromonas gingivalis. J Invest Clin Dent 3: 128-34
125. Reise M, Wyrwa R, Müller U, et al. (2012). Release of metronidazole from electrospun poly (L-lactide-co-D/L-lactide) fibers for local periodontitis treatment. Dental Mater 28: 179-88
126. Saboktakin MR, Tabatabaie RM, Maharramov A, Ramazanov MA. (2011). Development and in vitro evaluation of thiolated chitosan-poly (methacrylic acid) nanoparticles as a local mucoadhesive delivery system. Int J Biol Macromol 48: 403-7
127. Sachdeva S, Agarwal V. (2011). Evaluation of commercially available biodegradable tetracycline fiber therapy in chronic periodontitis. J Indian Soc Periodontol 15: 130-4
128. Saini R, Saini S, Sharma S. (2010). Periodontitis: a risk factor to respiratory diseases. Lung India 27: 189
129. Santos VR, Lima JA, Miranda TS, et al. (2012). Relationship between glycemic subsets and generalized chronic periodontitis in type 2 diabetic Brazilian subjects. Arch Oral Biol 57: 293-9
130. Sanz I, Alonso B, Carasol M, et al. (2012). Nonsurgical treatment of periodontitis. J Evid Based Dent Pract 12: 76-86
131. Schwach-Abdellaoui K, Vivien-Castioni N, Gurny R. (2000). Local delivery of antimicrobial agents for the treatment of periodontal diseases. Eur J Pharm Biopharm 50: 83-99
132. Shifrovitch Y, Binderman I, Bahar H, et al. (2009). Metronidazole-loaded bioabsorbable films as local antibacterial treatment of infected periodontal pockets. J Periodontol 80: 330-7
133. Sindhura Reddy N, Sowmya S, Bumgardner JD, et al. (2014). Tetracycline nanoparticles loaded calcium sulfate composite beads for periodontal management. Biochim Biophys Acta (Bba) Gen Subj 1840: 2080-90
134. Singh H, Sharma R, Joshi M, et al. (2014a). Transmucosal delivery of docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol. Under publication
135. Singh K, Arora N, Garg T. (2012a). RFID: a trustable security tool in pharmaceutical industry. Am J Pharm Tech Res 2: 113-27
136. Singh K, Arora N, Garg T. (2012b). Superbug: antimicrobial resistance due to NDM-1. Int J Institutional Pharmacy Life Sci 2: 58-66
137. Singh O, Garg T, Rath G, Goyal AK. (2014b). Microbicides for the treatment of sexually transmitted HIV infections. J Pharm 1-18
138. Somayaji B, Jariwala U, Jayachandran P, et al. (1998). Evaluation of antimicrobial efficacy and release pattern of tetracycline and metronidazole using a local delivery system. J Periodontol 69: 409-13
139. Soskolne WA. (1997). Subgingival delivery of therapeutic agents in the treatment of periodontal diseases. Crit Rev Oral Biol Med 8: 164-74
140. Stoltze K, Stellfeld M. (1992). Systemic absorption of metronidazole after application of a metronidazole 25% dental gel. J Clin Periodontol 19: 693-97
141. Taner I, Ozcan G, Doganay T, et al. (1994). Comparison of the antibacterial effects on subgingival microflora of two different resorbable base materials containing doxycycline. J Nihon Univ School Dent 36: 183-90
142. Tariq M, Iqbal Z, Ali J, et al. (2012). Treatment modalities and evaluation models for periodontitis. Int J Pharm Inv 2: 106-22
143. Tiwari G, Tiwari R, Rai AK. (2010). Studies on development of controlled delivery of combination drug (S) to periodontal pocket. Indian J Dent Res 21: 72-83
144. Tonetti M, Cugini M, Goodson J. (1990). Zero-order delivery with periodontal placement of tetracycline-loaded ethylene vinyl acetate fibers. J Periodont Res 25: 243-9
145. Van Dyke TE, Dave S. (2005). Risk factors for periodontitis. J Int Acad Periodontol 7: 3-7
146. Vandekerckhove BN, Quirynen M, Van Steenberghe D. (1997). The use of tetracycline-containing controlled-release fibers in the treatment of refractory periodontitis. J Periodontol 68: 353-61
147. Vasita R, Katti DS. (2006). Nanofibers and their applications in tissue engineering. Int J Nanomed 1: 15-30
148. Wade W, Moran J, Morgan J, et al. (1992). The effects of antimicrobial acrylic strips on the subgingival microflora in chronic periodontitis. J Clin Periodontol 19: 127-34
149. Wang L-C, Chen X-G, Zhong D-Y, Xu Q-C. (2007). Study on poly (vinyl alcohol)/carboxymethyl-chitosan blend film as local drug delivery system. J Mater Sci Mat Med 18: 1125-33
150. Wayakanon K, Thornhill MH, Douglas CI, et al. (2013). Polymersome-mediated intracellular delivery of antibiotics to treat Porphyromonas gingivalis-infected oral epithelial cells. FASEB J 27: 4455-65
151. Yalcin F, Demirel K, Onan U. (1998). Evaluation of adjunctive tetracycline fiber therapy with scaling and root planing: short-term clinical results. Periodont Clin Invest Official Publ Northeast Soc Periodont 21: 23-7
152. Zamani M, Morshed M, Varshosaz J, Jannesari M. (2010). Controlled release of metronidazole benzoate from poly epsilon-caprolactone electrospun nanofibers for periodontal diseases. Int Dent Rev 75: 179-85
153. Zhang S, Huang Y, Yang X, et al. (2009). Gelatin nanofibrous membrane fabricated by electrospinning of aqueous gelatin solution for guided tissue regeneration. J Biomed Mater Res A 90: 671-9
154. Zhao Y, Kang J, Tan T. (2006). Salt-, PH-and temperature-responsive semi-interpenetrating polymer network hydrogel based on poly (aspartic acid) and poly (acrylic acid). Polymer 47: 7702-10
155. Zilberman M, Elsner JJ. (2008). Antibiotic-eluting medical devices for various applications. J Control Release 130: 202-15
156. Zingale J, Harpenau L, Bruce G, et al. (2011). The effectiveness of scaling and root planing with adjunctive time-release minocycline using an open and closed approach for the treatment of periodontitis. Gen Dent 60: 300-5